Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-β and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation

por Vlahovic, G, Rabbani, Z N, Herndon, J E, Dewhirst, M W, Vujaskovic, Z
Publicado 2006

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final anal...

por Frasci, G, D'Aiuto, G, Comella, P, Thomas, R, Botti, G, Di Bonito, M, De Rosa, V, Iodice, G, Rubulotta, M R, Comella, G
Publicado 2006

Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis

por Yokoyama, H, Ikehara, Y, Kodera, Y, Ikehara, S, Yatabe, Y, Mochizuki, Y, Koike, M, Fujiwara, M, Nakao, A, Tatematsu, M, Nakanishi, H
Publicado 2006

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

por Clamp, A R, Mäenpää, J, Cruickshank, D, Ledermann, J, Wilkinson, P M, Welch, R, Chan, S, Vasey, P, Sorbe, B, Hindley, A, Jayson, G C
Publicado 2006

The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in mul...

por Sarbia, M, Stahl, M, von Weyhern, C, Weirich, G, Pühringer-Oppermann, F
Publicado 2006

Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial...

por Donskov, F, Hokland, M, Marcussen, N, Torp Madsen, H H, von der Maase, H
Publicado 2006

BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

por Fan, S, Meng, Q, Auborn, K, Carter, T, Rosen, E M
Publicado 2006

A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy

por Castano, A P, Liu, Q, Hamblin, M R
Publicado 2006

MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

por Burton, S, Brown, G, Daniels, I R, Norman, A R, Mason, B, Cunningham, D
Publicado 2006

The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk

por Melia, J, Dearnaley, D, Moss, S, Johns, L, Coulson, P, Moynihan, C, Sweetman, J, Parkinson, M C, Eeles, R, Watson, M
Publicado 2006

Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients

por Moureau-Zabotto, L, Ricci, S, Lefranc, J P, Coulet, F, Genestie, C, Antoine, M, Uzan, S, Lotz, J P, Touboul, E, Lacave, R
Publicado 2006

Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice

por Huynh, C K, Brodie, A M H, Njar, V C O
Publicado 2006

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma

por Wallard, M J, Pennington, C J, Veerakumarasivam, A, Burtt, G, Mills, I G, Warren, A, Leung, H Y, Murphy, G, Edwards, D R, Neal, D E, Kelly, J D
Publicado 2006

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer

por Kawakami, K, Ruszkiewicz, A, Bennett, G, Moore, J, Grieu, F, Watanabe, G, Iacopetta, B
Publicado 2006

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status

por Fritzsche, F, Gansukh, T, Borgoño, C A, Burkhardt, M, Pahl, S, Mayordomo, E, Winzer, K-J, Weichert, W, Denkert, C, Jung, K, Stephan, C, Dietel, M, Diamandis, E P, Dahl, E, Kristiansen, G
Publicado 2006

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

por Baas, P, Belderbos, J S A, Senan, S, Kwa, H B, van Bochove, A, van Tinteren, H, Burgers, J A, van Meerbeeck, J P
Publicado 2006

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

por Feliu, J, Salud, A, Escudero, P, Lopez-Gómez, L, Bolaños, M, Galán, A, Vicent, J-M, Yubero, A, Losa, F, De Castro, J, de Mon, M Á, Casado, E, González-Barón, M
Publicado 2006

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

por Betticher, D C, Hsu Schmitz, S-F, Tötsch, M, Hansen, E, Joss, C, von Briel, C, Schmid, R A, Pless, M, Habicht, J, Roth, A D, Spiliopoulos, A, Stahel, R, Weder, W, Stupp, R, Egli, F, Furrer, M, Honegger, H, Wernli, M, Cerny, T, Ris, H-B
Publicado 2006

General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial

por Wattchow, D A, Weller, D P, Esterman, A, Pilotto, L S, McGorm, K, Hammett, Z, Platell, C, Silagy, C
Publicado 2006

Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays

por Djuzenova, C S, Mühl, B, Fehn, M, Oppitz, U, Müller, B, Flentje, M
Publicado 2006